First Tracks Biotherapeutics, Inc. — Form 8-K

First Tracks Biotherapeutics entered into a Registration Rights Agreement dated October 19, 2026 with unnamed investors for resale of common stock shares. The Company must file an initial registration statement within 30 days and achieve SEC effectiveness within 60 days (or 5 business days if no SEC review). Investors receive 1.0% monthly liquidated damages (capped at 5% of purchase price) if registration deadlines are missed. The agreement grants investors piggyback registration rights, Rule 144 benefits, and broad indemnification provisions; counterparties and share counts are not disclosed in this execution version.